Shots:

• Bill & Melinda Gates Foundation provides $4.8M fund to AbCellera to develop Ab for infectious diseases including HIV- malaria & tuberculosis
• The focus of the agreement is to get benefit from AbCellera’s Ab discovery technology and development of vaccines with the improvement in QoL
• AbCellera’s single-cell screening technology is a combination of live-cell assays to develop therapies for targets such as membrane proteins- GPCRs and ion channels in multiple therapy areas. In 2017- AbCellera collaborated with Gates Foundation to discover mAb against 10 biomarkers associated with tuberculosis

Ref: AbCellera | Image: Twitter